| Technical Name | Development of Respiratory Syncytial Virus Vaccine by Inducing Mucosal Immunity | ||
|---|---|---|---|
| Project Operator | 醫學院小兒科 | ||
| Project Host | - | ||
| Summary | Respiratory Syncytial Virus (RSV) is one of the major pathogens causing lower respiratory tract infection. However, there is still no licensed RSV vaccine for clinical uses. Most vaccines are given parenterally aiming to induce systemic TB cell responses. Repeated failures have been encountered in the vaccine development for certain viruses such as HIV-1, HCVRSV. Mucosal vaccine may be a |
||
| Scientific Breakthrough | - |
||
| Industrial Applicability | - |
||
| Keyword | |||
| Notes | |||
- Contact
- futuretech.most@gmail.com
other people also saw